A 12-month follow-up of infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.

ABSTRACT:

Background

Prenatal opioid exposure has been associated with developmental deficits during infancy, but the literature is limited by simple group comparisons and lack of appropriate controls. Previously published research with the current sample documented unique associations between prenatal opioid exposure and developmental outcomes at three and six months, but less is known about associations later in infancy.

Method

The current study examined pre- and postnatal opioid and polysubstance exposure as predictors of parent-reported developmental status at 12 months of age. Participants were 85 mother-child dyads, oversampled for mothers taking opioid treatment medications during pregnancy. Maternal opioid and polysubstance use were reported using the Timeline Follow-Back Inte

SUBMITTER: Bierce L 

PROVIDER: S-EPMC10198960 | biostudies-literature | 2023 May-Jun

REPOSITORIES: biostudies-literature